Assessment of the heart failure pharmacotherapy of patients with continuous flow left-ventricular assist devices

International Journal of Artificial Organs

Volumn 35, Issue 3, 2012, Pages 177-179

  Jennings, Douglas L ^a   Jones, Mathew C ^b   Lanfear, David E ^a  

^a HENRY FORD HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

ACE inhibitors; Beta blockers; Drug therapy; Heart failure; Left ventricular assist devices

Indexed keywords

DRUG THERAPY; FIBER OPTIC SENSORS; HEART; LEFT VENTRICULAR ASSIST DEVICES;

ACE INHIBITORS; BETA-BLOCKERS; CONTINUOUS-FLOW; END-POINTS; FIRST YEAR; FOLLOW UP; HEART FAILURE; MEAN AGES; MULTIDISCIPLINARY TEAMS; POST-IMPLANTATION;

CARDIOLOGY;

CARVEDILOL; DIGOXIN; FUROSEMIDE; HYDRALAZINE; LISINOPRIL; LOSARTAN; METOPROLOL SUCCINATE; MILRINONE; NITRATE; OLMESARTAN; SILDENAFIL; SPIRONOLACTONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL DISCHARGE; HUMAN; IMPLANTATION; LEFT VENTRICULAR ASSIST DEVICE; MALE; PILOT STUDY; PRESCRIPTION; STATISTICAL SIGNIFICANCE;

EID: 84862737838     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000068     Document Type: Article

References (6)

1. Rose EA, Geljins AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435-1443. Medline. doi:10.1056/NEJMoa012175
2. Rogers JG, Aaronson KD, Boyle AJ, et al. Continuous flow left ventricular assist device improved functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 2010;55(17):1826-1834. Medline. doi:10.1016/j.jacc.2009.12.052
3. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation. 2005;112(12):e154-e235.Medline. doi:10.1161/CIRCULATIONAHA.105.167586
4. Cohn JN, Tam SW, Anand IS, et al. Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT. J Card Fail. 2007;13(5):331-339.Medline. doi:10.1016/j.cardfail. 2007.03.001
5. Klotz S, Jan Danser AH, Foronjy RF, et al. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure. J Am Coll Cardiol. 2007;49(11):1166-1174.Medline. doi:10.1016/j. jacc.2006.10.071
6. Birks EJ, George RS, Hedger M, et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation. 2011;123:381-390. Medline. doi:10.1161/CIRCULATIONAHA. 109.933960